Treatment of chronic obstructive pulmonary disease with autologous stem cells from adipose tissue is a safe and initial supportive treatment method that has shown effectiveness in improving the degree of dyspnea, reducing the severity of the disease on health; improve exercise capacity with increased 6-minute walking distance; improved quality of life with a decrease in mean SGRQ score, a decrease in the number of exacerbations, and an increase in the mean value of FEV1 during the 12-month follow-up period after treatment